0001104659-23-119962.txt : 20231120
0001104659-23-119962.hdr.sgml : 20231120
20231120170007
ACCESSION NUMBER: 0001104659-23-119962
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEWHALL CHARLES W III
CENTRAL INDEX KEY: 0001005544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 231423454
MAIL ADDRESS:
STREET 1: 1119 ST PAUL ST
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm2331055-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-11-16
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001005544
NEWHALL CHARLES W III
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
1
0
0
0
0
Common Stock
2023-11-16
4
M
0
7457
9.24
A
119589
D
Common Stock
2023-11-16
4
S
0
2500
28.01
D
117089
D
Director Stock Option (Right to Buy)
9.24
2023-11-16
4
M
0
7457
0
D
2015-01-21
2024-01-21
Common Stock
7457
0
D
Represents the number of shares of common stock sold to cover the exercise price of the employee stock options.
/s/ Timothy C. Dec, as attorney-in-fact
2023-11-20